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Abstract
Background—We set out to identify common genetic determinants of the length of RR and QT
intervals in 2,325 individuals from isolated European populations.
Methods and Results—We analyzed heart rate at rest, measured as RR interval, and length of
corrected QT interval for association to 318,237 SNPs. RR interval was associated to common
variants within GPR133, a G-Protein Coupled Receptor (rs885389, P = 3.9 × 10-8). QT interval
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was associated to the earlier reported NOS1AP gene (rs2880058, P = 2.00 × 10-10) and to a region
on chromosome 13 (rs2478333, P = 4.34 × 10-8), which is 100 kb from the closest known
transcript LOC730174 and has previously not been associated with length of QT interval.
Conclusion—Our results suggested association between RR interval and GPR133 and
confirmed association between QT interval and NOS1AP.
Keywords
genetics; heart rate; population
Quantitative electrocardiographic (ECG) measurements have been shown to be valuable and
non-invasive predictors of cardiovascular morbidity and mortality. In particular, increases in
resting heart rate and in the length of QT interval have been associated with increases in
cardiovascular risk.
Heart rate, often more accurately measured as the length in milliseconds of the RR interval
(heart rate = 60,000/RR), is a well known risk factor for morbidity in cardiovascular
disease1,2 and all-cause mortality.3 Heritability, linkage, and association studies have
suggested that RR interval is modified by common genetic variations4,5 but no RR modifier
variants have yet been consistently confirmed.
Cardiac repolarization can be strongly altered in Mendelian disorders due to mutations in
genes coding for ion channels subunits as in both Long QT Syndrome (OMIM 192500) and
Short QT Syndrome (OMIM 60962). Mildly increased QT intervals have also been
associated with increased cardiovascular morbidity and mortality compared to QT intervals
in the normal range.6,7 A QT modifying polymorphism near the NOS1AP gene has been
identified and successfully replicated.8,9,10,11,12,13
To extend knowledge of genetic determinants of the length of QT and RR intervals we
performed a genome-wide association (GWA) analysis on three isolated European
populations and then pooled the results via a meta-analysis performed on data for 2,325
subjects.
We chose to focus on isolated populations because of the lower genetic heterogeneity and
longer span of LD in isolated compared to outbred populations14,15 and the advantages
these confer for the study of complex traits. In addition, isolated populations tend to show a
lower level of environmental heterogeneity than the general population, which again can
favor the identification of variants affecting complex traits, as shown in one of the three
populations included in this meta-analysis.16
To fully investigate the contribution of isolated populations to gene mapping, a network
comprising five centers involved in the study of isolated populations was established
(European Special Population Research Network, EUROSPAN). Three of the participating
study locations (Italy, Scotland and The Netherlands) had ECG measurements available, and
their data were therefore included in the present work. We present here results from a meta-
analysis of GWA scans performed on these three genetically isolated populations on the
length of RR and QT intervals.
Methods
Genotypes and phenotypes
Genotypes were available for 1,175 subjects in the South Tyrolean population, 745
individuals from Orkney, and 800 in the population from the Netherlands. We genotyped
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318,237 SNPs for each individual, using the Illumina 300 HumanHap SNP Chip. Subjects
with genotypic call rate >97% were retained in the analysis. Patients with atrial fibrillation,
pacemaker and defibrillator implants as well as pregnant women were excluded from the
study.
We excluded from meta-analysis SNPs which in at least one of the study populations: i) had
minor allele frequency (MAF) <0.01; ii) were out of Hardy-Weinberg equilibrium (p<10-3)
or; iii) had a call rate <97%. All participants to each individual study gave informed consent.
Individual studies were approved by the competent Ethics Committees.
South Tyrol, Italy—Subjects were sampled in the framework of the MICROS study,
carried out in three isolated villages in Val Venosta (South Tyrol, Italy) in 2001-2003.17
Due to geographical, historical and political reasons, the entire region experienced
prolonged isolation from surrounding populations. The investigated population is
characterized by an old settlement, a small number of founders, high endogamy rates, slow
or null population expansion and negligible immigration.18 Information on participant’s
health status was collected through a standardized questionnaire and clinical examinations,
including ECG measurements. 12-lead resting ECGs were recorded using a digital recording
system (Mortara Portrait, Mortara, Milwakee, WI, USA). The Mortara portrait machine
determines QT interval by the proprietary XL-ECG algorithm which has not been fully
published but has shown to be in good accordance with other published ECG measurement
algorithms.19 Laboratory data were obtained from standard blood analyses. Joint genotype
and phenotype information was available for 970 subjects (409 men and 561 women).
Orkney Islands, Scotland (United Kingdom)—The Orkney Complex Disease Study
(ORCADES) is an ongoing family-based cross-sectional study taking place in the isolated
Scottish archipelago of Orkney. Genetic diversity is decreased compared to Mainland
Scotland, consistent with the high levels of endogamy historically. Data from 745
participants aged 18-100 years from a subgroup of ten islands were used in this analysis.
Blood samples were taken from fasting participants and over 200 health-related phenotypes
and environmental exposures were measured in each individual. Digital 10 second ECGs
were taken after at least 10 minutes supine rest, using a PC link with QT and RR intervals
calculated using CardioView software (NUMED cardiac diagnostics, Sheffield, UK). Joint
genotype and phenotype information was available for 679 subjects (315 men and 364
women).
Rucphen, the Netherlands—The Erasmus Rucphen Family (ERF) study was carried out
on a Dutch isolated population located in the Southwest of the Netherlands.20 The
population is characterized by rapid growth and minimal inward migration and has now
expanded up to 20,000 inhabitants. Within this population, a specific subpopulation based
on 20 couples (selected on the basis that they had at least 6 children baptized in the
community church between 1850 and 1900) has been defined. All living descendants of the
selected couples and their spouses (n≈3,000) have been recruited. All participants have been
invited to the research center and were screened for quantitative traits, assessing
cardiovascular, neuropsychiatric, endocrine, ophthalmologic and musculoskeletal functions.
A 10 seconds 12-lead ECG (on average, 8 to 10 beats) was recorded with an ACTA-ECG
(Esaote, Florence, Italy) with a sampling frequency of 500 Hz. All ECGs were processed by
the Modular ECG Analysis System (MEANS) to obtain ECG measurement and
interpretation. The MEANS determines common onsets and offsets for all 12 leads together
on one representative averaged beat, with the use of template matching techniques, has been
evaluated extensively and shown to have excellent correlation with diagnosis performed by
cardiologists.21 Joint genotype and phenotype information was available for 676 subjects
(252 men and 424 women).
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Statistical analysis
Between population homogeneity of study variables was assessed with the Kruskal-Wallis
rank sum test. To ensure a better adaptation of models residuals to normality, QT and RR
were transformed to Normal distribution using rank transformation to normality. Multiple
linear regression models were fitted to the normalized QT and RR, adjusting for age, sex,
and RR, and age, sex and body mass index (BMI), respectively. Sex-stratified models were
also estimated. GWA scans under an additive model were performed separately for each
population. The genomic control method was used to correct the distribution of p-values
which could be skewed in inbred populations.22,23
λ was estimated to be 1.6 in MICROS, 1.1 in ERF and 1.1 in Orkney. λ for the pooled
sample was 1.3. Association analyses were performed using the R package GenABEL.24,25
Evidence from single studies was pooled together using a fixed effect meta-analysis based
on inverse variance weighting.26 We set the global alpha for significance to 0.05. Under this
constraint, using the Bonferroni correction based on the conservative assumption that the
318,237 tests performed were independent, the genome-wide significance threshold was
defined as p≤1.57*10-7.
All locations on a physical map are referred to build 36 of the human genome reference
map. LD was computed using the R package genetics,27 and plots obtained with the R
package LDheatmap.28 All the analyses were performed using R.25
Results
Characteristics of each population sample are given in Table 1. There were significant
differences between populations for all study variables (p<0.0001). The MICROS
population was significantly younger than those from ERF (p<0.0001) and Orkney
(p<0.0001), while mean ages for ERF and Orkney populations were not significantly
different from each other (p=0.73). The Orkney sample had the highest BMI, whereas South
Tyrol showed the lowest value; all pairwise tests were significantly different (p<0.001). The
RR interval was shorter in the MICROS population than in ERF and Orkney samples, and
all pairwise tests were significantly different; average heart rate (60,000/RR) for the three
populations ranged from 60 (Orkney) to 67 (MICROS) beats per minute. QT interval was
significantly longer in Orkney sample than in MICROS, while no significant difference in
QT interval duration was detected in the remaining pairwise comparisons. Additional,
aggregated data were available for larger cohorts recruited for each study (a subset of which
was then genotyped). Such data include the prevalence of hypertension, diabetes, and
myocardial infarction, together with information on the use of beta-blocking drugs. All the
data are based on self-reporting. Data are shown as supplementary material (Table S-1).
RR interval
Table 2 shows population-specific and pooled results of the test of association between
length of RR interval (after adjusting for age, sex and BMI) and the 25 SNPs with lowest p-
values. For SNPs located within genes, gene names are reported as well. Two SNPs
(rs885389 and rs1725789) located in the GPR133 gene on chromosome 12 exceeded the
threshold of genome-wide significance (p=3.88*10-8 and 1.48*10-7, respectively). Two
SNPs are located in FRMD4A, two in AKT3, and one in RASGRF1, but none of them are
genome-wide significant. All of the above mentioned SNPs are intronic.
Figure 1 shows a detailed view of all SNPs present in GPR133. Boundaries of GPR133 are
shown as dotted vertical lines. Lack of significant association is evident for most of the gene
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sequence, with the exception of the 3′ portion of the gene with the two SNPs reaching
genome-wide significance and two more SNPs that emerged from background noise.
The rare allele of both SNPs is associated with a shortening of the length of RR interval (and
increased heart rate). For SNP rs885389, each risk allele confers a decrease of 14 ms in the
length of RR interval, while for SNP rs1725789 each risk allele causes a decrease of 16 ms;
this roughly corresponds to an increase of 1 beat per minute per risk allele in terms of heart
rate.
A figure showing results genome-wide is available as supplementary material (Figure S-1).
A graph of LD structure in GPR133 in each population is available as supplementary
material (Figure S-2). While no strong LD blocks were detected, the two genome-wide
significant SNPs are in strong LD (r2=0.68 in MICROS and Orkney, r2=0.69 in ERF).
When analyzing the data from men separately, one SNP on chromosome 1 reached genome-
wide significance (rs17706439, p=2.82*10-8), but it was not in proximity (<100kb) to any
known gene. No SNPs in GPR133 reached significance. In the analysis of the data from
women, we found two genome-wide significant SNPs; one on chromosome 7 (rs1874326,
p=9.79*10-8) and one on chromosome X (rs4610880, p= 1.44*10-7). rs1874326 is located in
the TRIM24 gene, known to mediate transcriptional control; rs4610880 is located in the
open reading frame CXorf36. No SNPs in GPR133 were significant in women alone.
QT interval
The 25 SNPs with lowest p-values after meta-analysis, sorted by ascending p-value, are
reported in Table 3 (for a graph of the genome wide association scan see supplementary
Figure S-3). Five SNPs located in or around NOS1AP reached genome-wide significance.
The most significant SNP (rs2880058, p=2*10-10) was located 25kb upstream of NOS1AP.
A genome-wide significant result was also observed for rs10494366, through which the
association between QT and NOS1AP polymorphisms was first identified.8 Association
results in NOS1AP gene are shown in Figure 2. LD structure in NOS1AP gene is available
as supplementary material (Figure S-4).
One SNP on chromosome 13 was also above the genome-wide threshold for significance
(rs2478333, p=4.34*10-8). It is located more than 100 kb from the closest putative locus
(LOC730174) and 300kb from the nearest known gene, succinate-CoA-ligase (SUCLA2).
In the meta-analysis performed on the female subsample (n=1,349) we identified two SNPs
achieving genome-wide significance, rs2880058 (p= 1.03*10-9) and rs6670339
(p=1.24*10-7); both of them are in or around NOS1AP and also reached genome-wide
significance in the pooled analysis (Table 3). When analyzing the male subsample (n=976),
we did not identify any genome-wide significant hits.
Discussion
Meta-analysis of GWA scans for RR interval allowed us to identify two SNPs reaching
genome-wide significance, located in the gene GPR133.
To the best of our knowledge, only one previous GWA study was performed to investigate
the genetic contribution to the length of RR interval,29 without identifying any genome-
wide significant signals. The authors made results available through the dbGAP database;
however, we were not able to compare the region in which we found the strongest signal,
since the published results lack SNPs between 129,840,347 bp and 130,588,160 bp, with
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GPR133 spanning 130,004,790 bp to 130,189,786 bp (distances of the closest SNPs to
GPR133 being about 160 and 400 kb, respectively).
Ours is the first study to identify significant SNPs associated with the length of RR interval.
Two SNPs reached genome-wide significance, rs885389 and rs1725789. These are located
in the 3′ region of GPR133 and are in strong but not complete LD.
We replicated association of NOS1AP to the length of QT interval adjusted for age, sex and
RR interval. Additional confounding factors, such as QT prolonging drugs and
cardiovascular disease status were not included in the analysis. Both previous studies8 and
our results consistently identified association between SNPs in the 5′ region of NOS1AP
and upstream of NOS1AP coding sequence, and the length of QT interval. In addition, we
identified a genome-wide significant hit with SNP rs2478333. This SNP is located more
than 100kb from the closest putative locus and 300kb from the nearest characterized gene.
Our findings on the genetic determinants of the length of QT interval allow us to verify the
importance of NOS1AP and to identify a single SNP on chromosome 13 reaching genome-
wide significance although far away from any known gene.
One limitation of the present study is the lack of independent replication. In addition,
functional demonstration of the effect of GPR133 on RR interval and of NOS1AP on QT
interval still needs to be provided.
GPR133 is a gene coding for a G-Protein Coupled Receptor (GPCR).30. Expression data
retrieved on Gene Expression Omnibus (GEO) showed that GPR133 is expressed in atria,
ventricles, and septal myocardial tissue (GEO accession numbers: GDS651, GDS1557,
GDS1559 and GDS2206).
At present, GPCRs belonging to the rhodopsin GPCR family, in particular adrenergic
receptors, have been extensively studied for their influence on heart activity and widely used
as pharmacological targets.31
We undertook a search of an available database (GLIDA) of GPCRs and their ligands in
order to better characterize GPR133.32 We performed a similarity search (based on
sequence), to identify GPCRs which could have structural similarities with GPR133. Among
GPCRs stored in the GLIDA database, those demonstrating the highest similarity were
ELTD1, CELSR1, EMR1 and LPHN1. Several members of the families of cadherins,
latrophilins and ETL receptors were shown as being similar to GPR133. Previous work
showed that ELTD1 (previous name, ETL) is developmentally regulated in heart.33 We
checked for association of ELTD1, CELSR1, EMR1 and LPHN1 with the length of RR
interval, but found no evidence of association; no p-value <10-4 was identified in any of the
genes or in the regions 100kb up- and downstream. In conclusion, we propose a role for
GPR133 in affecting the length of electrocardiographic RR interval and heart rate. Beta-
adrenergic receptors are members of GPCRs targeted by beta-blockers drugs for the
management of cardiac arrhythmias; GPR133 could therefore represent an ideal novel target
for a pharmacological approach. Assigning a ligand to this orphan receptor and identifying
the causal variant are among the priorities to confirm a role of GPR133 in determining heart
rate.
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Figure 1.
Results of association between RR interval and SNPs in the GPR133 gene.
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Figure 2.
Results of association between QT interval and SNPs in the NOS1AP gene.
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Table 1
Descriptive statistics of the three study populations
Variable MICROS Orkney ERF
N (% of males) 970 (42%) 679 (46%) 676 (37%)
Age [years]; Mean (SD) 45.3 (16.1) 53.6 (15.7) 53.5 (15.2)
BMI [kg/m2]; Mean (SD) 25.48 (4.89) 27.75 (4.85) 26.93 (4.65)
RR interval [ms]; Mean (SD) 898 (152) 1009 (156) 966 (159)
QT interval [ms]; Mean (SD) 398 (29) 410 (30) 401 (30)
ms = milliseconds; SD = Standard Deviation
Distribution of age, BMI, RR interval and QT interval were significantly different across studies, according to Kruskal-Wallis rank sum test.
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